Preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer

Abstract Pancreatic cancer will gradually become the second leading cause of cancer death due to its poor suitability for surgical treatment, frequent recurrence and metastasis, and insensitivity to radiotherapy and chemotherapy. Strategies for precise early detection and effective targeted treatmen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hengli Yang, Ping Zhao, Yonggang Zhou, Qiaoying Li, Wenbin Cai, Zongxia Zhao, Jian Shen, Kechun Yao, Yunyou Duan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b35f9948432a4da18cc6ec36388f9661
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b35f9948432a4da18cc6ec36388f9661
record_format dspace
spelling oai:doaj.org-article:b35f9948432a4da18cc6ec36388f96612021-12-02T16:30:24ZPreparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer10.1038/s41598-021-82602-92045-2322https://doaj.org/article/b35f9948432a4da18cc6ec36388f96612021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-82602-9https://doaj.org/toc/2045-2322Abstract Pancreatic cancer will gradually become the second leading cause of cancer death due to its poor suitability for surgical treatment, frequent recurrence and metastasis, and insensitivity to radiotherapy and chemotherapy. Strategies for precise early detection and effective targeted treatment of pancreatic cancer are urgently needed. Because of its unique advantages, molecular targeted contrast-enhanced ultrasound imaging (CEUI) has generated new opportunities to overcome this challenge. The aim of this study was to explore multifunctional nanobubbles named IR780-NBs-DTX as novel ultrasound contrast agents (UCAs) for dual-mode targeted imaging and photothermal ablation combined with chemotherapy for pancreatic cancer. An optimized “film hydration method” was used to prepare IR780-NBs-DTX in this research. The characteristics and ability of the new UCAs were detected via in vitro, in vivo and ex vivo experiments. The initial dose of 0.15 mg IR-780 iodide/1.0 mg DTX was considered to be the best formula for IR780-NBs-DTX, and the concentration of 6 ×106 bubbles/mL was best for CEUI. The excellent characteristics of IR780-NBs-DTX, including a uniform nanoscale particle size (349.8± 159.1 nm, n= 3), good performance in dual-mode imaging, high stability and reliable biocompatibility, were also proven. In the in vitro cell experiments, IR780-NBs-DTX targeted more pancreatic cancer cells than the control treatments, and the targeting rate was approximately 95.6± 1.7%. Under irradiation with an 808 nm laser, most cells died. Furthermore, the in vivo study demonstrated that IR780-NBs-DTX could precisely detect pancreatic cancer through near infrared fluorescence (NIRF) imaging and CEUI, and the tumor almost disappeared at 18 days after combined treatment. In ex vivo experiments, immunohistochemistry (IHC) and immunofluorescence (IF) showed that the expression of HSP70 increased and that of PCNA decreased, and many apoptotic tumor cells were observed by TUNEL staining in the IR780-NBs-DTX group. The newly prepared IR780-NBs-DTX are novel nanosized UCAs with high efficiency for dual-mode molecular targeted imaging and combined therapy, and they may have future potential applications in the precise detection and effective targeted therapy of small and metastatic lesions in the early stage of pancreatic cancer.Hengli YangPing ZhaoYonggang ZhouQiaoying LiWenbin CaiZongxia ZhaoJian ShenKechun YaoYunyou DuanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-18 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hengli Yang
Ping Zhao
Yonggang Zhou
Qiaoying Li
Wenbin Cai
Zongxia Zhao
Jian Shen
Kechun Yao
Yunyou Duan
Preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer
description Abstract Pancreatic cancer will gradually become the second leading cause of cancer death due to its poor suitability for surgical treatment, frequent recurrence and metastasis, and insensitivity to radiotherapy and chemotherapy. Strategies for precise early detection and effective targeted treatment of pancreatic cancer are urgently needed. Because of its unique advantages, molecular targeted contrast-enhanced ultrasound imaging (CEUI) has generated new opportunities to overcome this challenge. The aim of this study was to explore multifunctional nanobubbles named IR780-NBs-DTX as novel ultrasound contrast agents (UCAs) for dual-mode targeted imaging and photothermal ablation combined with chemotherapy for pancreatic cancer. An optimized “film hydration method” was used to prepare IR780-NBs-DTX in this research. The characteristics and ability of the new UCAs were detected via in vitro, in vivo and ex vivo experiments. The initial dose of 0.15 mg IR-780 iodide/1.0 mg DTX was considered to be the best formula for IR780-NBs-DTX, and the concentration of 6 ×106 bubbles/mL was best for CEUI. The excellent characteristics of IR780-NBs-DTX, including a uniform nanoscale particle size (349.8± 159.1 nm, n= 3), good performance in dual-mode imaging, high stability and reliable biocompatibility, were also proven. In the in vitro cell experiments, IR780-NBs-DTX targeted more pancreatic cancer cells than the control treatments, and the targeting rate was approximately 95.6± 1.7%. Under irradiation with an 808 nm laser, most cells died. Furthermore, the in vivo study demonstrated that IR780-NBs-DTX could precisely detect pancreatic cancer through near infrared fluorescence (NIRF) imaging and CEUI, and the tumor almost disappeared at 18 days after combined treatment. In ex vivo experiments, immunohistochemistry (IHC) and immunofluorescence (IF) showed that the expression of HSP70 increased and that of PCNA decreased, and many apoptotic tumor cells were observed by TUNEL staining in the IR780-NBs-DTX group. The newly prepared IR780-NBs-DTX are novel nanosized UCAs with high efficiency for dual-mode molecular targeted imaging and combined therapy, and they may have future potential applications in the precise detection and effective targeted therapy of small and metastatic lesions in the early stage of pancreatic cancer.
format article
author Hengli Yang
Ping Zhao
Yonggang Zhou
Qiaoying Li
Wenbin Cai
Zongxia Zhao
Jian Shen
Kechun Yao
Yunyou Duan
author_facet Hengli Yang
Ping Zhao
Yonggang Zhou
Qiaoying Li
Wenbin Cai
Zongxia Zhao
Jian Shen
Kechun Yao
Yunyou Duan
author_sort Hengli Yang
title Preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer
title_short Preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer
title_full Preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer
title_fullStr Preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer
title_full_unstemmed Preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer
title_sort preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/b35f9948432a4da18cc6ec36388f9661
work_keys_str_mv AT hengliyang preparationofmultifunctionalnanobubblesandtheirapplicationinbimodalimagingandtargetedcombinationtherapyofearlypancreaticcancer
AT pingzhao preparationofmultifunctionalnanobubblesandtheirapplicationinbimodalimagingandtargetedcombinationtherapyofearlypancreaticcancer
AT yonggangzhou preparationofmultifunctionalnanobubblesandtheirapplicationinbimodalimagingandtargetedcombinationtherapyofearlypancreaticcancer
AT qiaoyingli preparationofmultifunctionalnanobubblesandtheirapplicationinbimodalimagingandtargetedcombinationtherapyofearlypancreaticcancer
AT wenbincai preparationofmultifunctionalnanobubblesandtheirapplicationinbimodalimagingandtargetedcombinationtherapyofearlypancreaticcancer
AT zongxiazhao preparationofmultifunctionalnanobubblesandtheirapplicationinbimodalimagingandtargetedcombinationtherapyofearlypancreaticcancer
AT jianshen preparationofmultifunctionalnanobubblesandtheirapplicationinbimodalimagingandtargetedcombinationtherapyofearlypancreaticcancer
AT kechunyao preparationofmultifunctionalnanobubblesandtheirapplicationinbimodalimagingandtargetedcombinationtherapyofearlypancreaticcancer
AT yunyouduan preparationofmultifunctionalnanobubblesandtheirapplicationinbimodalimagingandtargetedcombinationtherapyofearlypancreaticcancer
_version_ 1718383952514777088